Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gabapentin + thiamine + cobalamin is a combination drug used primarily for the treatment of neuropathic pain, diabetic neuropathy, nerve damage, and vitamin B deficiencies associated with nerve pain[1][2][4]. **Gabapentin**, a small molecule anticonvulsant, acts as an alpha-2-delta ligand, modulating calcium channel activity and diminishing excitatory neurotransmitter release to reduce pain signaling[2][3][4]. **Thiamine (vitamin B1)** enhances carbohydrate metabolism, suppresses protein glycation and oxidative stress, and improves neuronal energy status[4]. **Cobalamin (vitamin B12, as either cyanocobalamin or methylcobalamin)** supports myelin synthesis, neuronal regeneration, and modulates pain pathways via sensory neuron inhibition and neurotransmitter regulation[4]. B vitamins synergize with gabapentin to enhance pain relief and reduce adverse effects, allowing lower doses of gabapentin for similar efficacy[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on gabapentin + thiamine + cobalamin.